2020
DOI: 10.1007/s11033-020-05887-5
|View full text |Cite
|
Sign up to set email alerts
|

Investigation of 8-methoxy-3-(4-nitrobenzoyl)-6-propyl-2H-chromen-2-one as a promising coumarin compound for the development of a new and orally effective antileishmanial agent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 48 publications
0
0
0
Order By: Relevance
“…Scopoletin (6-methoxy-7-hydroxy-coumarin) increased the phagocytic ability of macrophages in a human based monocytic cell line [43]. Several 7-methoxy-8-[3-methylpent-2-enyl] coumarin (osthole) derivatives showed meaningful anti-tumor activity in cell culture models [42][43][44][45][46][47][48]. Moreover, the 4-hydroxycoumarin impairs the ability of melanoma cells to metastasize [49] and although this effect is probably not immune related, it may contribute to presenting tumorous antigens to the immune system.…”
Section: Coumarins With Potential Immunity Enhancing Effectsmentioning
confidence: 99%
“…Scopoletin (6-methoxy-7-hydroxy-coumarin) increased the phagocytic ability of macrophages in a human based monocytic cell line [43]. Several 7-methoxy-8-[3-methylpent-2-enyl] coumarin (osthole) derivatives showed meaningful anti-tumor activity in cell culture models [42][43][44][45][46][47][48]. Moreover, the 4-hydroxycoumarin impairs the ability of melanoma cells to metastasize [49] and although this effect is probably not immune related, it may contribute to presenting tumorous antigens to the immune system.…”
Section: Coumarins With Potential Immunity Enhancing Effectsmentioning
confidence: 99%